Matossian, M. D.
Chang, T.
Wright, M. K.
Burks, H. E.
Elliott, S.
Sabol, R. A.
Wathieu, H.
Windsor, G. O.
Alzoubi, M. S.
King, C. T.
Bursavich, J. B.
Ham, A. M.
Savoie, J. J.
Nguyen, K.
Baddoo, M.
Flemington, E.
Sirenko, O.
Cromwell, E. F.
Hebert, K. L.
Lau, F.
Izadpanah, R.
Brown, H.
Sinha, S.
Zabaleta, J.
Riker, A. I.
Moroz, K.
Miele, L.
Zea, A. H.
Ochoa, A.
Bunnell, B. A.
Collins-Burow, B. M.
Martin, E. C.
Burow, M. E. http://orcid.org/0000-0002-0642-6630
Funding for this research was provided by:
National Institute of General Medical Sciences (U54 GM104940)
National Institutes of Health (R01-CA125806-04, 1R15CA176496-01A1, R01-CA174785-A1)
Article History
Received: 15 February 2021
Accepted: 7 June 2021
First Online: 9 August 2021
Declarations
:
: The authors declare that they have no competing interests.
: Human-derived tumor tissue was considered IRB-exempt (IRB Reference Number 15–812,428). All animal experiments were consistent with protocols and guidelines approved by Tulane Institute for Animal Care and Use Committee (Protocol Number 4299R).
: Informed consent was obtained from all individual participants included in the study.